Personal Genome Diagnostics, Inc.

Personal Genome Diagnostics, Inc. — FDA 510(k) Submissions

Personal Genome Diagnostics, Inc. has submitted 1 FDA 510(k) premarket notifications since 2024, of which 0 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include High Throughput Sequencing Based Tumor Profiling Test Of Circulating Cell-free Nucleic Acids . Use the specialty filter in the sidebar to narrow results.